FDA turns down Ardelyx’s chronic kidney disease drug and asks for another trial

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 29, 2021 at 11:42 PM.

  1. #1 cafead, Jul 29, 2021 at 11:42 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Ardelyx drug tenapanor was rejected by the FDA as a treatment for a complication experienced by chronic kidney disease patients. The regulatory decision came two weeks after the company received an FDA letter citing deficiencies in the drug application.

    article source
     
    Quote

Reply to Thread